“Favorable Safety Profile of Tirbanibulin Ointment 1% for Actinic Keratosis: Pooled Results from Two Phase III Studies”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 6, Oct. 2020, p. s120, https://doi.org/10.25251/skin.4.supp.120.